Cargando…

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408

Detalles Bibliográficos
Autores principales: Bress, Adam P., Papademetriou, Vasilios, Feinglos, Mark N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961393/
https://www.ncbi.nlm.nih.gov/pubmed/29784703
http://dx.doi.org/10.2337/dci17-0061
_version_ 1783324712844132352
author Bress, Adam P.
Papademetriou, Vasilios
Feinglos, Mark N.
author_facet Bress, Adam P.
Papademetriou, Vasilios
Feinglos, Mark N.
author_sort Bress, Adam P.
collection PubMed
description
format Online
Article
Text
id pubmed-5961393
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-59613932019-06-01 Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408 Bress, Adam P. Papademetriou, Vasilios Feinglos, Mark N. Diabetes Care Blood Pressure Targets and Type 2 Diabetes American Diabetes Association 2018-06 2018-05-11 /pmc/articles/PMC5961393/ /pubmed/29784703 http://dx.doi.org/10.2337/dci17-0061 Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Blood Pressure Targets and Type 2 Diabetes
Bress, Adam P.
Papademetriou, Vasilios
Feinglos, Mark N.
Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title_full Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title_fullStr Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title_full_unstemmed Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title_short Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
title_sort response to comment on bress et al. effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial. diabetes care 2017;40:1401–1408
topic Blood Pressure Targets and Type 2 Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961393/
https://www.ncbi.nlm.nih.gov/pubmed/29784703
http://dx.doi.org/10.2337/dci17-0061
work_keys_str_mv AT bressadamp responsetocommentonbressetaleffectofintensiveversusstandardbloodpressuretreatmentaccordingtobaselineprediabetesstatusaposthocanalysisofarandomizedtrialdiabetescare20174014011408
AT papademetriouvasilios responsetocommentonbressetaleffectofintensiveversusstandardbloodpressuretreatmentaccordingtobaselineprediabetesstatusaposthocanalysisofarandomizedtrialdiabetescare20174014011408
AT feinglosmarkn responsetocommentonbressetaleffectofintensiveversusstandardbloodpressuretreatmentaccordingtobaselineprediabetesstatusaposthocanalysisofarandomizedtrialdiabetescare20174014011408